Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2216801
Max Phase: Preclinical
Molecular Formula: C62H78F3N15O11S
Molecular Weight: 1298.46
Molecule Type: Small molecule
Associated Items:
ID: ALA2216801
Max Phase: Preclinical
Molecular Formula: C62H78F3N15O11S
Molecular Weight: 1298.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cn1c(CNc2ccc(C(=N)NCCCCNC(=O)C[C@H](NC(=O)c3ccc(C4(C(F)(F)F)N=N4)cc3)C(=O)NCCCOCCOCCOCCCNC(=O)CCCC[C@@H]3SC[C@@H]4NC(=O)N[C@@H]43)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21
Standard InChI: InChI=1S/C62H78F3N15O11S/c1-79-48-22-17-42(59(87)80(29-23-54(83)84)50-11-4-5-24-67-50)36-45(48)73-51(79)38-72-44-20-15-40(16-21-44)56(66)70-26-7-6-25-69-53(82)37-46(74-57(85)41-13-18-43(19-14-41)61(77-78-61)62(63,64)65)58(86)71-28-9-31-90-33-35-91-34-32-89-30-8-27-68-52(81)12-3-2-10-49-55-47(39-92-49)75-60(88)76-55/h4-5,11,13-22,24,36,46-47,49,55,72H,2-3,6-10,12,23,25-35,37-39H2,1H3,(H2,66,70)(H,68,81)(H,69,82)(H,71,86)(H,74,85)(H,83,84)(H2,75,76,88)/t46-,47-,49-,55-/m0/s1
Standard InChI Key: FWPJLUJFQUSPKW-QZMVMWQSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1298.46 | Molecular Weight (Monoisotopic): 1297.5678 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Michaelis S, Marais A, Schrey AK, Graebner OY, Schaudt C, Sefkow M, Kroll F, Dreger M, Glinski M, Koester H, Metternich R, Fischer JJ.. (2012) Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2)., 55 (8): [PMID:22494098] [10.1021/jm3001339] |
Source(1):